Clear imaging of pancreatic cells through the development of a novel fluorescent probe

September 11, 2015, Agency for Science, Technology and Research (A*STAR), Singapore
Clear imaging of pancreatic cells through the development of a novel fluorescent probe
A pancreatic islet stained with the fluorescent dye, Two Photon-alpha (TP-α), showing brightly stained alpha cells. Credit: A*STAR Singapore Bioimaging Consortium

A fluorescent imaging probe developed by A*STAR researchers has allowed scientists for the first time to visualize the detailed three-dimensional distribution of alpha cells in the pancreas of mice1. The probe could enhance diabetes research and shine a light on more effective treatment of the disease.

A key function of the pancreas is to release hormones—namely glucagon and insulin—into the bloodstream to control sugar levels. Glucagon and insulin are stored and released by alpha and beta cells respectively. The alpha and beta cells work so closely together to regulate blood sugar that they form cell clumps known as inside the pancreas. Within the islets, glucagon raises the amount of glucose in the bloodstream, and insulin is released when become too high. Disruption of this regulation is largely responsible for diabetes.

Until now, a suitable fluorescent imaging probe to produce clear pictures of the individual components in live pancreatic islets has eluded scientists.

"It was this gap in bioimaging that we wanted to fill," explains Young-Tae Chang of the A*STAR Singapore Bioimaging Consortium, who led the project. "We wanted to develop a fluorescent probe that could selectively stain glucagon-producing , and that was suitable for two-photon microscopy."

This relatively new form of microscopy uses near-infrared light to excite fluorescent dyes. Two photons are absorbed in each excitation, minimizing light-scattering within the tissue. This allows for deeper tissue penetration, more localized and coherent imaging, and quicker observation of cells than is possible via conventional microscopy techniques.

Chang and his team, with collaborators from the National University of Singapore, generated a two-photon fluorescent dye library comprising 80 different compounds. They then used pancreatic cell lines to screen the compounds and identify one that selectively binds to alpha cells and brightly fluoresces. The dye, named Two Photon-alpha (TP-α), performed particularly well when tested on islets isolated from mice, specifically showing alpha cells and their distribution in 3D (see image).

"We have not tested the TP-α probe on human islets yet," states Chang. "If it works, potential applications include diabetes research, as well as possibly islet transplant procedures for diabetes patients. TP-α could be used to monitor the survival and condition of alpha cells, for example."

The team will now focus on testing TP-α in human islets in the laboratory and inside the body. They also hope to extend their two-photon-probe hunt to find one suitable for imaging insulin-producing .

Explore further: 'Crosstalk' gives clues to diabetes

More information: "Glucagon-secreting alpha cell selective two-photon fluorescent probe TP-α: For live pancreatic islet imaging." Journal of the American Chemical Society 137, 5355–5362 (2015). dx.doi.org/10.1021/ja5115776

Related Stories

'Crosstalk' gives clues to diabetes

June 15, 2015

Sometimes, listening in on a conversation can tell you a lot. For Mark Huising, an assistant professor in the Department of Neurobiology, Physiology and Behavior at the UC Davis College of Biological Sciences, that crosstalk ...

Study describes underlying cause of diabetes in dogs

August 17, 2015

In a new effort, researchers from the University of Pennsylvania and Baylor College of Medicine have used advanced imaging technology to fill in details about the underlying cause of canine diabetes, which until now has been ...

New clues to treat juvenile diabetes

April 21, 2015

UC Davis Assistant Professor Mark Huising is a recipient of The Hartwell Foundation 2014 Individual Biomedical Research Award to support his early-stage research toward a cure for juvenile diabetes. Diabetes affects 10 percent ...

Recommended for you

From receptor structure to new osteoporosis drugs

November 20, 2018

Researchers at the University of Zurich have determined the three-dimensional structure of a receptor that controls the release of calcium from bones. The receptor is now one of the main candidates for developing new drugs ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.